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Abstract 
Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating illness. Symptoms 
include profound fatigue and distinctive post-exertional malaise (PEM). We asked whether a submaximal exercise test 
would prove useful for identifying different patterns of tissue oxygen utilization in individuals with ME/CFS versus 
healthy subjects. Such a test has potential to aid with ME/CFS diagnosis, or to characterize patients’ illness.
Methods: A case–control study of 16 patients with ME/CFS compared to 16 healthy controls completing a 3-min 
handgrip protocol was performed. Response was measured using near-infrared spectroscopy, resulting in measure-
ments of oxygenated (O2Hb) and deoxygenated hemoglobin (HHb) over wrist extensors and flexors. Changes in 
O2Hb (delta (d)O2Hb) and HHb (dHHb) absorbance between the first and last contraction were calculated, as were the 
force–time product of all contractions, measured as tension-time index (TTI), and ratings of perceived exertion (RPE).
Results: Individuals with ME/CFS demonstrated smaller dO2Hb and dHHb than controls. However, after adjusting for 
TTI and change in total hemoglobin (delta (d)tHb), differences in dO2Hb and dHHb were reduced, with large overlap-
ping variances. RPE was significantly higher for cases than controls, particularly at rest.
Conclusions: Relative to controls, participants with ME/CFS demonstrated higher RPE, lower TTI, and reduced dO2Hb 
and dHHb during repetitive handgrip exercise, although considerable variance was observed. With further study, sub-
maximal exercise testing may prove useful for stratifying patients with a lower propensity for inducing PEM, and have 
the ability to establish baseline intensities for exercise prescription.
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Background
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome 
(ME/CFS) is a debilitating illness of unknown etiol-
ogy characterized by profound fatigue that is markedly 
exacerbated by physical or mental activity. Over one mil-
lion Americans experience symptoms compatible with 
ME/CFS and the Canadian Community Health Survey 
indicates that an estimated 350,000 Canadians report 
a diagnosis of the syndrome [1–3]. Furthermore, those 
with ME/CFS consistently rank as having more unmet 
medical and homecare needs, less food security, more 
marginalization, more need of help with tasks, greater 
difficulty in social situations, less ability to work, and 
Open Access
*Correspondence:  ruth.miller@bccdc.ca 
1 School of Population and Public Health, British Columbia Centre 
for Disease Control, University of British Columbia, 655 West 12th Avenue, 
Vancouver, BC V5Z 4R4, Canada
Full list of author information is available at the end of the article
Page 2 of 11Miller et al. J Transl Med  (2015) 13:159 
lower personal income than those with most other 
chronic diseases [3–5].
Many studies have reported reduced exercise capacity 
in individuals with ME/CFS compared to healthy con-
trols [6–10]. Indeed, a recent systematic review reported 
that more high quality studies encompassing a greater 
number of study subjects found decreased physiological 
exercise capacity in individuals with ME/CFS compared 
to the number and size of studies reporting no difference 
[9], although publication bias may explain these findings.
A hallmark of ME/CFS is a distinctive post-exertional 
malaise (PEM), also referred to as a symptom flare or 
“crash”, which occurs following physical or cognitive exer-
tion and can last from days to weeks. The PEM response 
can occur following testing of ME/CFS patients’ exercise 
capacity, particularly after the maximal exercise testing 
protocols commonly used in ME/CFS, in which an individ-
ual performs exercise to the point of exhaustion [11–13].
Submaximal exercise testing, in which individuals per-
form at a workload below their maximum capacity, may 
be able to distinguish between cases with ME/CFS and 
healthy controls or to stratify individuals with ME/CFS, 
with the benefit of decreasing the risk of PEM follow-
ing testing. Submaximal testing may also reach a larger 
group of patients, as some individuals may not be able to 
perform a maximal exercise test [14, 15] and the ethics of 
using maximal testing in this group of patients has been 
questioned [16]. Additionally, submaximal testing may 
be useful in screening for metabolic myopathies, such 
as mitochondrial disease, that may provide alternative 
explanations for ME/CFS patients’ symptoms.
Few studies have investigated ME/CFS using submaxi-
mal exercise testing and the conclusions they have drawn 
are inconsistent. Both Nijs et al. and Keller et al. investi-
gated submaximal exercise testing’s ability to predict the 
results of maximal testing [17, 18]. Nijs et al. found that 
submaximal oxygen uptake, defined as 75% of the age-
predicted heart rate, was correlated with peak oxygen 
uptake, although the correlation was not strong enough 
for prediction of peak oxygen uptake for clinical pur-
poses. However, Keller et al. concluded that submaximal 
testing could not predict the results of a maximal test, 
particularly in patients experiencing PEM. Other experi-
ments investigated submaximal testing using multiple 
types of exercise—exercise cycle, foot pedal, and elbow 
flexors. Using the pedal test, ME/CFS patients displayed 
significantly lower recovery rates for tissue oxygen satu-
ration [19], whereas the cycle and handgrip tests sug-
gested that only perceived exertion differed between ME/
CFS cases and controls [20, 21]. To date, no studies have 
investigated the wrist flexors and extensor muscle oxy-
genation during repetitive handgrip exercise in ME/CFS 
patients.
Like pulse oximetry, near-infrared spectroscopy (NIRS) 
is a non-invasive technique for measuring oxygen satu-
ration. Whereas pulse oximetry estimates arterial blood 
oxygenation, the more sophisticated NIRS technology 
enables tissue measurements of both oxygenated hemo-
globin (O2Hb) and deoxygenated hemoglobin (HHb). 
Total hemoglobin (tHb) can be determined from the 
sum of O2Hb and HHb, providing a surrogate measure of 
local blood volume in muscle beneath the NIRS probes 
[22]. The procedure required to perform NIRS is simple 
with limited equipment required, making replication of 
our procedure by other laboratories straightforward.
It has been hypothesized that exercise testing might aid 
in the diagnosis of ME/CFS if suspected patients’ exercise 
outcomes are reliably distinct from those of healthy indi-
viduals [13]. Even if exercise testing proved not to have 
diagnostic utility, it may also be useful in characterizing 
a patient’s illness—for example, assessing the disability 
level of ME/CFS patients and providing a baseline against 
which a clinician can prescribe and evaluate an exercise 
and physical activity prescription. This study is the first 
of its kind to use NIRS to compare O2Hb and HHb in 
wrist flexors and extensor muscles during a submaximal, 
repetitive handgrip test in patients with ME/CFS and 
healthy controls. The objective was to identify different 
patterns of tissue oxygen utilization in individuals with 
ME/CFS compared to healthy controls, which would 
provide evidence that the poor exercise tolerance and 
rapid fatigue seen in ME/CFS is due to peripheral mus-
cle dysfunction. We hypothesized that ME/CFS patients’ 
perceived exertion would be higher, and that their total 
workload, as quantified by the tension-time index (TTI), 
would be lower during the exercise protocol as compared 
to healthy controls. We further hypothesized that the 
decrease in O2Hb normally observed during submaximal 




All participants were recruited as part of the Chronic 
Complex Diseases (CCD) study at the University of Brit-
ish Columbia, a case–control study designed to compare 
participants with chronic complex diseases using multi-
ple platforms, from metagenomics and transcriptomics to 
exercise testing. Each participant with a physician-based 
diagnosis of ME/CFS fitting the Canadian case definition 
[23]—the most specific case definition identified at the 
time of study inception—was compared to one healthy 
person matched on gender and age within 5  years. To 
facilitate comparison with other studies, participants 
were also classified as to whether they met the Fukuda 
(CDC) case definition [24]. Participants were members of 
Page 3 of 11Miller et al. J Transl Med  (2015) 13:159 
the general public who learned of the study through post-
ings in newspapers and on websites or through physician 
referrals, and were recruited between 2012–05–23 and 
2014–04–23. If participants had no exclusion criteria (age 
<19  years, unable to understand English, another diag-
nosed medical condition that fully explains symptoms, 
or antibiotic therapy in the last month), they were taken 
for pre-screening clinical assessment and documenta-
tion. All participants signed informed consent forms that 
were approved by the ethics board. The study aimed to 
recruit 25 cases with ME/CFS and 25 healthy controls, 
a number sufficient to identify a significant odds ratio of 
20 between cases with ME/CFS and healthy controls, and 
chosen with the larger metagenomics arm of the study in 
mind, which is not described here.
Pre-screening included verification of the disease diag-
nosis and collection of age, height, weight, blood pres-
sure, heart rate and ethnicity for each participant, as well 
as laboratory tests for hemoglobin, ferritin and acyl car-
nitine, all reported as part of this study. Additionally, pre-
screening collected details of self-reported demographics 
and histories, including completion of the Fatigue Sever-
ity Scale (FSS) [25] and a physician review of systems, 
which involved counting the number of tender points 
to indicate level of body pain. Further laboratory blood 
screening tests were also performed. Orthostatic intoler-
ance was determined by observing any of the following 
between sitting and standing: decrease in systolic blood 
pressure of 20  mmHg or more, decrease in diastolic 
blood pressure of 10 mmHg or more, or increase in heart 
rate of 30 BPM or more.
Exercise testing protocol
Experimental design
A repetitive handgrip protocol was performed based on 
the protocol of Jeppesen et  al. [26], and NIRS was used 
to monitor relative changes in O2Hb, HHb and tHb lev-
els, as described previously [27, 28]. Before beginning 
the exercise test, all participants were screened using 
the AHA/ACSM Health/Fitness Facility Preparticipation 
Screening Questionnaire [29].While in the sitting posi-
tion with the arms supported on a table, skinfold thick-
ness was measured over the optode sites at the midpoint 
of the muscle belly, and NIRS optodes were applied to 
the wrist extensors and flexors groups, bilaterally. Resting 
blood pressure, heart rate and Borg’s rating of perceived 
exertion (RPE) [30] were assessed at baseline. Base-
line monitoring of NIRS was performed for 5  min. The 
maximal voluntary contraction (MVC) for a handgrip 
was determined for the dominant arm (self-reported as 
the hand the participant wrote with) by performance of 
three MVCs. Forty percent of the MVC was calculated, 
which was the target force for the submaximal repetitive 
handgrip protocol. After a 5 min rest period, the par-
ticipant performed repetitive handgrip contractions for 
3 min; the participant was instructed to target 40% of the 
MVC at a contraction rate of 30 per minute and a duty 
cycle of 1:1. The last eight control participants performed 
a second repetitive handgrip protocol on the contralat-
eral hand at 30% of the MVC in order to better match 
the absolute force produced by the cases with ME/CFS. 
This was preceded by measures of the MVC on the con-
tralateral arm followed by a repetitive handgrip protocol 
at 30% of this MVC. At the end of the handgrip protocol, 
vital signs and RPE were repeated and the participants 
were instructed to sit at rest for an additional 5 min.
Repetitive handgrip protocol
A grip force transducer was connected to a PowerLab 
data acquisition unit that displayed output using Lab-
Chart software (ADInstruments, Colorado Springs, CO) 
on a computer monitor. Real-time visual feedback via 
the monitor display was provided to participants dur-
ing the MVC and submaximal contractions. After three 
MVCs were performed within 5%, the participant rested 
for 5 min and then began the 3 min repetitive handgrip 
test [31]. RPE was quantified using a modified Borg scale, 
recorded before and immediately after completion of the 
test. The participants were required to choose a num-
ber between 0 and 10, anchored by “nothing at all” and 
“very, very severe”, respectively [30]. The target for the 
submaximal contractions was cued by observation of a 
computer monitor that displayed each contraction with 
a marker at 40% of the MVC for all subjects and at 30% of 
the MVC for the second test of the last eight control sub-
jects. The repetition rate and duty cycle were cued by an 
audio recording that repetitively stated “contract-relax” 
for a 3 min period for a total of 90 contractions. One of 
the investigators provided verbal feedback to coach par-
ticipants about the timing and force of the contractions 
in order to match the duty cycle and the 40 or 30% MVC 
target. The force–time product, termed the tension-time 
index (TTI), was calculated as the integral of all contrac-
tions by the LabChart software in Newton-seconds.
Near infrared spectroscopy (NIRS)
Muscle oxygenation and hemodynamics of the left and 
right flexor digitorum and extensor carpi radialis brevis 
(ECRB) were monitored continuously using a four-chan-
nel continuous-wave NIRS device (Oxymon Mk II, Arti-
nis, The Netherlands). This device emits two wavelengths 
in the near infrared spectrum, 760 and 850 nm, that are 
preferentially absorbed by HHb and O2Hb, respectively. 
The principle of NIRS and calculation of NIRS-derived 
parameters have been described previously [32–34]. In 
brief, NIRS software contains algorithms based on the 
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Beer-Lambert law [35] that calculate the absorbance of 
chromophores (O2Hb and HHb) based on the emitted 
reflected and received light and the absorbance is stated 
in arbitrary units (AU). Fluctuations in chromophore 
absorbance coincide with intermittent contractions, 
and hence, compression and release of the vasculature 
in the exercising muscle. Because of these fluctuations, 
the change in O2Hb [delta (d) O2Hb] and HHb (dHHb) 
chromophore concentration was calculated from the 
midpoint of the first contraction to the midpoint of the 
last contraction. The peak and nadir values of these con-
tractions were determined in Oxysoft to four decimal 
places. The average of these two values was defined as the 
midpoint. The sum of O2Hb and HHb was also used to 
provide a measure of tHb, a surrogate for blood volume 
beneath the optode site. Skinfold thickness was measured 
prior to placement of NIRS optodes using a skinfold cali-
per in order to ensure that the adipose tissue covering the 
muscles was less than 10 mm. After the skin was cleaned 
with alcohol, four NIRS optodes were placed directly 
on the skin over the left and right flexor digitorum and 
ECRB. Position was standardized using anatomical land-
marks and palpitation of the muscle belly. Optodes were 
fixed in place with double-sided sticky circular adhe-
sives (3M™ Double-Stick Discs) and further secured with 
strips of low allergy adhesive tape (Hypafix®). Continuous 
recording of NIRS measures were performed throughout 
the rest periods, MVCs, and grip protocols.
Statistical analysis
Statistical analyses comparing cases with ME/CFS to 
healthy controls were performed using STATA V12.1. 
Due to the non-normal distribution of the data, univari-
ate analysis was performed using Fisher’s Exact Test to 
compare categorical variables and Mann–Whitney rank 
sum tests for continuous and ordinal variables. Sub-
groups were compared using a Kruskal–Wallis test and 
correlation between two continuous variables measured 
using Spearman’s rank correlation. Initial adjustment of 
the NIRS output for TTI and dtHb was performed by 
division of dO2Hb and dHHb by TTI or dtHb. Multivari-
ate analyses were performed using linear regression with 
dummy variables for categorical variables, and residu-
als were confirmed to be normally distributed using 
the Shapiro–Wilk normality test. Curves resulting from 
exercise testing were depicted using a lowess smoother. 
Lowess carries out a locally weighted regression of the y 
variable (O2Hb or HHb) on the x variable (time) to dis-
play the graph as a smooth curve. This enabled visual 
comparisons among participants that would have been 
masked by the participant curves showing the usual fluc-
tuations in O2Hb and HHb that occur during repetitive 
contraction and relaxation of the wrist flexors. Delta (d)
O2Hb and dHHb were considered the primary outcome 
variables.
Results
The CCD study pre-screened 102 people and excluded 
52:24 with another diagnosis (e.g., sleep apnea, hypo-
thyroidism, etc.), three who did not meet the case defi-
nitions, 11 that declined to participate, and 14 eligible 
patients that could not be matched to a control. The 
final overall study cohort comprised 25 cases with ME/
CFS and 25 healthy controls. Of these, 22 ME/CFS cases 
and 21 healthy controls performed the repetitive hand-
grip protocol for the CCD exercise testing sub-study. 
Due to the underrepresentation of males amongst exer-
cise testing participants, four male CFS cases and four 
male healthy controls were excluded from analysis to 
avoid confounding from pooling gender data. Addition-
ally, one ME/CFS case that was subsequently diagnosed 
with sleep apnea and another that exhibited considerable 
muscle spasm and was unable to complete the protocol 
were excluded, as well as one healthy control with arthri-
tis in their hand. The final cohort for analysis included 
16 ME/CFS cases and 16 healthy controls, all female 
and largely Caucasian, and age-matched within a 5-year 
strata (Table 1). All cases and no healthy controls fit both 
the Canadian case definition and the CDC Fukuda defini-
tion of ME/CFS (Table 1).
Cases and controls did not differ significantly in eth-
nicity, hemoglobin, ferritin, or acyl carnitine levels; how-
ever, cases with ME/CFS had significantly higher scores 
on the FSS and a greater number of tender points, as well 
as greater body mass indexes (BMI) than controls, by a 
mean of 3.7 kg/m2. Despite the difference in BMI, skin-
fold differences over optode sites did not differ between 
groups in the 19 subjects for which it was recorded.
Fifteen of 16 cases with ME/CFS and all healthy con-
trols completed the test with contractions for greater 
than 170 s (Table 2). The median TTI for ME/CFS cases 
was 26% lower than that of controls (P = 0.0008). Borg’s 
RPE was significantly higher both at rest and at the end of 
the repetitive handgrip protocol in the cases versus con-
trols (P < 0.0001 and 0.001, respectively) (Table 2). Inter-
estingly, the most significant difference in Borg’s RPE was 
at rest, when most cases with ME/CFS rated a level of 
exertion from simply attending the study, whereas most 
controls rated resting perceived exertion levels as “0—
nothing at all”.
Figure  1 shows an example of the chromophore 
changes of a single participant during the handgrip pro-
tocol—a rapid decrease in oxygenated hemoglobin and 
corresponding increase in deoxygenated hemoglobin, 
and a gradual increase in total hemoglobin/local blood 
volume. Lowess-smoothed levels of O2Hb and HHb 
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throughout the test for individual participants are shown 
in Figure  2, while Figure  3 summarizes the change, or 
delta, in each individual’s O2Hb and HHb between the 
test start and end.
Comparing the change in O2Hb and HHb between test 
start and end revealed that cases with ME/CFS displayed 
a smaller dO2Hb (P = 0.004) and dHHb (P = 0.008) com-
pared to healthy controls (Table  2, Figure  3 upper pan-
els). The significant differences remained after adjusting 
for dtHb, a surrogate for muscle blood volume (P = 0.04) 
and dtHb did not differ between groups (P = 0.31). After 
adjusting for TTI, the difference between cases and 
controls in dHHb (Figure  3b lower panel) was reduced 
(P  =  0.06). Similarly after adjusting for TTI the differ-
ence in dO2Hb between cases and controls was reduced 
(Figure  3a lower panel), but remained significant at 
P = 0.02. However, considerable overlap between dO2Hb 
values among cases and controls was observed, particu-
larly after TTI adjustment (Table  2; Figure  3a). Similar 
results were obtained when the area under the curve for 
O2Hb and HHb throughout the experiment was used as 
the outcome measure, with the difference between cases 
and controls reduced after adjusting for TTI (data not 
shown).
Table 1 Characteristics of study participants
Values are N (%) or median (inter-quartile range (IQR). BMI Body Mass Index.
* P values are univariable exact test for discrete variables and rank sum for continuous variables. Significant P values are indicated in italics.
** Skinfold thickness measurement for 10 ME/CFS cases and 9 controls only.
ME/CFS cases (N = 16) Healthy controls (N = 16) P value* case vs. control*
Age (years) 55 (46.5;62.5) 54 (49.5;65) 0.76
BMI (kg/m2) 25.1 (21.7;31.5) 20.8 (19.2;23.9) 0.03
Skinfold thickness (mm)** 8 (7;10) 7 (5;10) 0.49
Ethnicity (Caucasian vs. other) 15 (94%) 13 (81%) 0.60
Fukuda definition 16 (100%) 0 (0%) <0.0005
Fatigue Severity Scale 61 (56.5;63) 17 (13.5;21.5) <0.0005
Orthostatic intolerance 1 (6.3%) 4 (25.0%) 0.3
Number of tender points 1 (0;6) 0 (0;0) 0.009
Hemoglobin (g/L) 134 (130;137) 131.5 (125.5;137.5) 0.47
Ferritin (μg/L) 43.5 (25;73.5) 43 (24;84) 1.00
Acyl carnitine (umol/L) 11.5 (8.3;15.0) 12.3 (8.9;14.0) 1.00
Table 2 Results of exercise test by participant
Results are N (%) for discrete variables or Median (IQR) for continuous and ordinal variables. dO2Hb Delta-oxy-hemoglobin, dHHb delta-deoxy-hemoglobin, dtHb delta-
total hemoglobin, AU arbitrary unit and TTI tension-time index.
P values are univariate exact test for discrete variables and rank sum for continuous and ordinal variables. Significant P values are indicated in italics. Confidence inter-
vals not provided due to non-parametric analyses.
* Ordinal variable
** One CFS case did not report Borg at 3 min due to lightheadedness and the need to quickly lie supine.
CFS cases (N = 16) Healthy controls (N = 16) P value case vs. control
Test length (s) 177.1 (176.1;177.5) 176.3 (175.9;177.4) 0.60
TTI (Newton-seconds) 11,388 (8,463;13,934) 15,382 (12,921;16,974) 0.008
Borg at rest* 1.5 (1;2) 0 (0;0) <0.0005
Borg at end*,** 3 (3;4) 2.5 (1.5;3) 0.01
dHHb (AU) 4.3 (3.4;10.4) 15.3 (9.1;24.2) 0.008
dHHb/dtHb (AU) 0.8 (0.6;1.5) 1.9 (1.2;3.3) 0.04
dHHb/TTI (AU/Newton-seconds) 0.0004 (0.002;0.001) 0.0009 (0.0006;0.002) 0.06
dO2Hb (AU) 0.2 (−4.2;1.4) −6.7 (−12.9;−3.6) 0.004
dO2Hb/dtHb (AU) 0.2 (−0.5;0.4) −0.9 (−2.3;−0.2) 0.04
dO2Hb/TTI (AU/Newton-seconds) 0.00002 (−0.0005;0.0001) −0.0005 (−0.001;−0.003) 0.02
dtHb (AU) 5.2 (2.1;6.9) 9.8 (0.8;13.6) 0.31
dtHb/TTI (AU/Newton-seconds) 0.0005 (0.0002;0.0008) 0.0006 (0.00006;0.0009) 1.000
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Since the range of symptoms within ME/CFS may 
vary, we also considered whether three measures that 
differ amongst ME/CFS sufferers were correlated 
with oxygen utilization: level of fatigue, body pain and 
orthostatic intolerance. We were unable to find a sig-
nificant correlation between any of these measures and 
dO2Hb or dHHb within ME/CFS cases in our study 
(Table  3). We also considered whether RPE may be 
µ
Figure 1 Changes in oxygenated hemoglobin [arbitrary units (AU)], deoxygenated hemoglobin (AU), and total hemoglobin (AU) of the right flexor 
digitorum during repetitive contractions of 3 min duration in one representative subject. Note the repetitive fluctuations that coincide with the 
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Figure 2 a Oxygenated hemoglobin levels throughout test before adjusting for tension-time index (TTI) (Newton-seconds) (upper panel) and after 
adjusting for TTI (lower panel). b Deoxygenated hemoglobin levels [arbitrary units (AU)] throughout test before adjusting for TTI (upper panel) and 
after adjusting for TTI (lower panel). Orange Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), pale blue dash healthy control, red bold 
mean ME/CFS and royal blue bold mean healthy control. Curves were smoothed using lowess-smoother.
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correlated with level of body pain, however, no signifi-
cant correlations were found between level of body pain 
and RPE at rest (P = 0.6) or RPE at 3 minutes (P = 1.0). 
Finally we hypothesized that lower TTI may be related 
to dysautonomia in ME/CFS patients, which we inves-
tigated through orthostatic intolerance. Since only four 
ME/CFS patients had orthostatic intolerance, statistical 
significance was not achieved (P = 0.1), but it was nota-
ble that ME/CFS cases with orthostatic intolerance had 
lower median values for TTI (8,778 vs. 11,436 Newton-
seconds) and two of the four ME/CFS individuals with 
orthostatic intolerance had the two lowest TTI values 
seen in the study.
To account for the effect of other variables on dO2Hb, 
we entered ME/CFS case versus healthy control, TTI, 
dtHb, Borg at rest, age, BMI, ethnicity, FSS, orthos-
tatic intolerance, number of tender points, ferritin, and 
hemoglobin, into a regression model with dO2Hb as the 
dependent variable. The only factors that were signifi-
cant predictors of dO2Hb were dtHb (P = 0.0125), BMI 
(P  =  0.025) and age, which was only just a significant 
predictor at the 0.05 level (P = 0.049) (Table 4). Similarly, 
substituting dHHb as the dependent variable also found 
dtHb and BMI to be significant predictors of dHHb after 
adjusting for the above variables (P = <0.0005 and 0.025 
respectively) (data not shown).
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ME/CFS case 40% MVC control 30% MVC control
Figure 3 a Delta-oxygenated hemoglobin [arbitrary units (AU)] values for cases, controls, and 30% maximal voluntary contraction (MVC) controls, 
before (upper panel) and after (lower panel) adjusting for tension-time index (TTI) (Newton-seconds). b Delta-deoxygenated hemoglobin values 
before (upper panel) and after (lower panel) adjusting for TTI. Orange crosses mean, green dash mean plus standard deviation and purple dash mean 
minus standard deviation.
Table 3 Relation of Fatigue Severity Scale, number of tender points and orthostatic intolerance to dO2Hb and dHHb
N = 16
P value are Spearman’s rank correlation coefficient for FSS and number of tender points and rank sum for orthostatic intolerance.
FSS Fatigue Severity Scale, dO2Hb delta-oxy-hemoglobin, dHHb delta-deoxy-hemoglobin and AU arbitrary unit.
* Median (IQR).
FSS Number of tender points Orthostatic intolerance
Spearman’s rho P Spearman’s rho P Yes* No* P
dO2Hb (AU) 0.198 0.5 −0.2293 0.4 −0.4 (−5.0;0.52) 0.6 (−4.2;2.3) 0.9
dHHb (AU) −0.2385 0.4 0.0785 0.8 5.3 (4.3;10.0) 4.2 (2.7;12.4) 0.9
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The range of dO2Hb values was similar for cases with 
ME/CFS and controls, at −38.9–6.4 and −32.4–5.4 
respectively (Figure  3), with respective standard devia-
tions of 10.7 and 10.5. However, one ME/CFS case sig-
nificantly extended the range with an uncharacteristically 
large delta. This participant was in the 50–55  year age 
stratum, of Caucasian ethnicity, and their only distinctive 
characteristic was a low BMI (15.6  kg/m2). We divided 
ME/CFS cases into three groups according to their 
dO2Hb: (1) “Low” dO2Hb <−5 (N  =  4); (2) “Medium” 
−5  ≤  dO2Hb  <  5 (N  =  10); and (3) “High” dO2Hb ≥5 
(N  =  2). There were no significant differences in age, 
BMI, ethnicity, fatigue severity, number of tender points, 
orthostatic intolerance, hemoglobin, ferritin, or acyl car-
nitine between the subgroups.
In order to better match the absolute force produced by 
the cases with ME/CFS, a subset of eight controls com-
pleted a duplicate test at 30% MVC. Controls who com-
pleted the test at 30% MVC did not significantly differ 
from cases in any of the variables investigated in Table 1 
(data not shown); however, it must be noted that power 
to detect differences between 30% cases and controls was 
low, due to the small number of controls who repeated 
the test. Median test length for ME/CFS cases and 30% 
MVC controls did not differ (P  =  0.81), nor did TTI 
(P  =  1.00), unlike the comparison between cases with 
ME/CFS and 40% MVC healthy controls. Comparison of 
cases with ME/CFS to the eight controls who performed 
the test at 30% MVC removed significant differences in 
dO2Hb (P = 0.20) and dHHb (P = 0.11), before and after 
adjusting for TTI (dO2Hb P = 0.33, dHHb P = 0.20) and 
dtHb (dO2Hb, P = 0.076, dHHb P = 0.076).
Two participants with ME/CFS suffered adverse reac-
tions to the study, presenting as muscle spasm and 
hypotension. Additionally, three ME/CFS participants 
with particularly low levels of HHb throughout the study 
were referred to a metabolic clinic. All three have tested 
negative for mitochondrial disease.
Discussion
We identified a significant difference in oxygenated and 
deoxygenated hemoglobin levels between cases with 
ME/CFS and healthy controls during a three-minute 
submaximal handgrip exercise testing procedure. How-
ever, after adjusting for total hemoglobin or the force at 
which the procedure was performed, these differences 
were reduced. Furthermore, particularly after adjust-
ing for TTI, we observed significant overlap in dO2Hb 
and dHHb between cases with ME/CFS and controls, 
and after adjusting for multiple factors in a multivari-
able model, case versus control did not have a significant 
effect on dO2Hb or dHHb, indicating that neither meas-
ure is appropriate for diagnostic testing.
Although our observations indicate that tissue oxy-
genation levels during submaximal exercise testing may 
not be useful in differentiating cases with ME/CFS from 
healthy controls, the large range in deoxyhemoglobin 
levels seen in participants with ME/CFS suggested that 
submaximal exercise testing could conceivably be used 
to subtype individuals with ME/CFS, perhaps into low, 
medium and high categories. Such deoxyhemoglobin-
based subtyping could be used in determining base-
lines for exercise prescription and screening for adverse 
responses. Additionally, submaximal exercise testing may 
flag patients with metabolic myopathies [36, 37] whose 
symptoms resemble those of ME/CFS. We observed 
extremely low HHb values during exercise testing in 
three study participants; they were referred for further 
testing, however, genetic testing for inherited mitochon-
drial disease revealed no abnormalities.
Although we did not observe substantial differences in 
oxygen saturation between cases and controls, other dif-
ferences were apparent. ME/CFS cases performed the 
procedure at significantly lower TTI than healthy con-
trols, suggesting that the force at which the handgrip 
was squeezed is one possible explanation for the differ-
ence in unadjusted blood oxygenation levels. However, 
after adjusting for TTI alone, differences in dO2Hb and 
dHHb remained, albeit reduced. Reduced TTI may also 
be related to patients with dysautonomia, as two ME/CFS 
patients in this study with orthostatic intolerance had 
particularly low TTI however, further studies would be 
required to confirm this. An alternative explanation for 
the lower TTI is reduced redistribution of cardiovascu-
lar output to exercising muscles resultant from impair-
ment or lack of fitness in ME/CFS patients. Reduced 
fitness may result from patients with ME/CFS’s aversion 
Table 4 Multivariable regression of dO2Hb
BMI Body mass index, RPE rating of perceived exertion and AU arbitrary unit.
Significant P values are indicated in italics.
Factor P value 95% Confidence interval




dtHb (AU) 0.025 −0.78:−0.59
Borg RPE at rest 0.76 −3.43:2.52
Age (years) 0.049 −0.82:−0.0025
BMI (kg/m2) 0.025 −0.12:1.57
Ethnicity (caucasian vs other) 0.71 −13.62:9.40
Fatigue Severity Scale 0.36 −0.86:0.33
Orthostatic intolerance 0.17 −19.10:3.59
Number of tender points 0.38 −0.72:1.82
Hemoglobin (g/L) 0.87 −0.41:0.48
Ferritin (μg/L) 0.52 −0.028:0.054
Page 9 of 11Miller et al. J Transl Med  (2015) 13:159 
to physical activity due to fear of fatigue. This aversion 
increasingly perpetuates deconditioning, similar to the 
pain catastrophizing theory [38]. We chose a procedure 
that used the flexor digitorum, since this muscle is regu-
larly activated while using computers and other devices, 
even in a sedentary state, so is less likely to be affected 
by deconditioning. Indeed, preservation of upper versus 
lower extremity musculature has been shown in hospi-
talized patients [39] and other chronic diseases such as 
COPD [40]. Furthermore, handgrip grip procedures have 
been shown to correlate with cardiopulmonary exercise 
testing using a cycle [41].
Our choice of protocol also meant that our test was 
less exhausting than other submaximal tests using 
methods such as an exercise cycle [20]. Even so, cases 
with ME/CFS perceived a greater level of exertion dur-
ing the test, as measured by the Borg RPE scale. In fact, 
the median modified Borg rating for ME/CFS cases 
after the procedure was three and the highest seven, 
which corresponds to “very severe”. This difference in 
perceived exertion has previously been observed in 
ME/CFS patients and may be explained by central per-
ception. Wallman et  al. 2007 suggested that ME/CFS 
patients may have augmented afferent feedback, making 
them feel a gain in perceived effort. Furthermore, the 
procedure was tolerated very poorly for two individuals 
with ME/CFS, suggesting that even submaximal testing 
may carry a risk of PEM.
Because this was a sub-study within a larger investiga-
tion of complex chronic disease, the case–control sam-
ple sizes that were appropriate for the other study aims 
resulted in some limitations with respect to the exercise 
testing work. The small sample size meant that there 
was only ~50% power to detect a difference in dO2Hb 
between individuals with ME/CFS and healthy controls 
given the mean and standard deviations seen in this 
study. Therefore it is possible that we may have missed 
differences between groups, even more so in the sub-
set of eight controls who repeated the procedure at 30% 
MVC. Despite these limitations, significant differences 
in dO2Hb were observed between groups, nonetheless, 
experiments using larger sample size would be beneficial 
to confirm our findings.
To our knowledge no studies have investigated gen-
der differences in submaximal exercise testing in ME/
CFS. However, maximal exercise testing has shown 
that women have lower exercise capacity, and therefore 
pooling gender data in studies with an unequal gender 
may confound results. [42] Due to the low numbers of 
male participants in our study, we therefore chose to 
remove their results from analysis, thus it is uncertain 
whether our findings are generalizable to male ME/CFS 
sufferers. Cases with ME/CFS and healthy controls were 
matched within a 5-year age stratum however, due to 
difficulties in recruiting, no further matching was made. 
ME/CFS cases had also significantly higher BMI than 
controls thus it would have been beneficial to match for 
BMI. However, skinfold thickness, which may have an 
impact on measurement of blood oxygenation, did not 
differ between cases and controls in the 19 individuals 
for which it was recorded. It may also have been ben-
eficial to match participants on fitness levels, as seen 
in other studies [19–21], and additional measures that 
may affect results, such as blood flow, could also have 
been collected during the study and considered in mul-
tivariable analysis. However, the effect of blood flow was 
likely captured in dtHb, which proved to be a significant 
predictor of blood oxygenation in our study. Finally, 
in future studies, it may be informative to repeat the 
test after 24  h. Preliminary findings suggest that some 
patients with ME/CFS experience a drop in anaerobic 
threshold that can be measured on the second of two 
daily maximal cardiopulmonary exercise tests, a find-
ing not seen in healthy, deconditioned controls [11–13]; 
however, no studies to date investigating ME/CFS using 
submaximal testing have compared results on subse-
quent days.
Conclusions
This submaximal exercise testing protocol revealed 
attenuated changes in oxygenated and deoxygenated 
hemoglobin, which may be attributable to poor exer-
cise tolerance and rapid fatigue seen in ME/CFS com-
pounded by decreased fitness. Because of the variable 
responses among participants, it does not provide a 
clear distinction between cases with ME/CFS and 
healthy controls and is therefore not a useful diagnostic 
marker. However, testing did reveal a disproportionate 
level of perceived exertion and lower force produc-
tion in cases with ME/CFS, and in two cases, adverse 
responses to low levels of exercise. The repetitive hand-
grip protocol may be useful to screen individuals for 
adverse responses and other conditions, including mito-
chondrial disease. It may also be useful for stratifying 
ME/CFS sufferers to determine appropriate levels of 
exercise prescription.
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